Updates are available Erratum dated 2017-10-01
Click to view Erratum: https://doi.org/10.1038/nm1017-1241d
-
Authors
Stadler, Christiane R
Bähr-Mahmud, Hayat
Celik, Leyla
Hebich, Bernhard
Roth, Alexandra S
Roth, René P
Karikó, Katalin
Türeci, Özlem
Sahin, Ugur
- License Information
-
More Information
Article History
Received: 20 December 2016
Accepted: 16 May 2017
First Online: 12 June 2017
Change Date: 20 July 2017
Change Type: Erratum
Change Details: In the version of this article initially published, in the “Polymer/lipid-based formulation of mRNA” section of the Online Methods, the text incorrectly stated that mRNA was in 190 ml rather than 190 µl of cold DMEM. The error has been corrected in the HTML and PDF versions of the article.
Competing interests
: C.R.S. is Head of Bispecific Antibodies at BioNTech and has ownership interest in patent applications. H.B.-M. is Deputy Head of Bispecific Antibodies at BioNTech and has ownership interest in a patent application. L.C. is a member of Bispecific Antibodies at BioNTech and has ownership interest in a patent application. K.K. is Vice President of BioNTech RNA and has ownership interest in patent applications. Ö.T. has ownership interest in patent applications. U.S. is cofounder of BioNTech and has ownership interest (including patents) in TRON and BioNTech.
Free to read: This content has been made available to all.
